BioSpecifics Technologies
Biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date.
Employees
Enterprise value
$540m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
$540m Valuation: $540m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.